Symbol: |
PDDC1
|
Description: |
Parkinson disease 7 domain containing 1 [Source:HGNC Symbol;Acc:26616]
|
Location: |
Chr11:767220-777501[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:110
Gene |
Compound |
Gen_sig |
Exp_pattern |
PDDC1 |
NSC 405361 |
0.022 |
Down |
PDDC1 |
Morpholine-N-dithiocarbamate |
0.028 |
Down |
PDDC1 |
MNQ |
0.042 |
Down |
PDDC1 |
NSC 49692 |
0.026 |
Up |
PDDC1 |
RAPAMYCIN PRODRUG |
0.017 |
Up |
PDDC1 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.048 |
Up |
PDDC1 |
Aspidospermin |
0.033 |
Down |
PDDC1 |
6H-Pyrido[4,3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-, (SP-4-1)-tetrachloroplatinate(2-) (2:1) |
0.025 |
Up |
PDDC1 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.031 |
Up |
PDDC1 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.016 |
Up |
PDDC1 |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3-methoxy- phenyl)methylene]-, hydrochloride |
0.012 |
Down |
PDDC1 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.013 |
Up |
PDDC1 |
Choline, hydroxide, 2-methoxy- 3-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt |
0.028 |
Down |
PDDC1 |
Nonanamide, N-(2-aminoethyl)- N-[2-[(1-oxononyl)amino]ethyl]- |
0.031 |
Down |
PDDC1 |
ANTINEOPLASTIC-654379 |
0.016 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:79
Total:6 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev]  Next Last 
|